Stephen OHara - INGEN TECHNOLOGIES Director

IGNT -- USA Stock  

USD 0.0001  0.0001  50.00%

  Director
Dr. Stephen OHara, M.D., is a Director of Ingen Technologies, Inc. The Consumer Research Council of America, an independent organization based in Washington, D.C. recently ranked Dr. Stephen OHara among the top two percent of clinical neurologists nationwide. He attended Stanford University and graduated in 1975 with a BS degree in biology and performed honors research in the laboratory of Dr. Donald Kennedy, who subsequently served as President of Stanford University. Dr. OHara obtained his M.D. from Northwestern University in 1979, where he became president of the Northwestern chapter of the American Medical Student Association, then proceeded to complete his residency in neurology at UCLA in 1983
Age: 56  Director Since 2005  Ph.D    
951-688-7840  http://www.ingen-tech.com
O'Hara is boardcertified in neurology through the American Board of Psychiatry and Neurology. Since completing his residency, Dr. O'Hara has continued to teach the residents in the neurology program at UCLA while maintaining a private practice in Century City, California for the past 16 years with an emphasis on geriatric neurology and disorders of balance.

Management Efficiency

The company has return on total asset (ROA) of (2.02) % which means that it has lost $2.02 on every $100 spent on asset. This is way below average.
The company currently holds 4.76 M in liabilities. INGEN TECHNOLOGIES INC has Current Ratio of 0.03 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Richard AndersonMedtronic plc
2015
Graham BakerSmith Nephew SNATS
2017
Gail BoudreauxZimmer Biomet Holdings
2012
Jeffrey RhodesZimmer Biomet Holdings
2015
Susan SiegelAlign Technology
2017
Nicholas ValerianiEdwards Lifesciences Corporatio
2014
Kevin DallasAlign Technology
2018
Syed JafryZimmer Biomet Holdings
2018
Charles LiamosInsulet Corporation
2014
Howard CoxStryker Corporation
1974
Michael LeavittMedtronic plc
2011
Michelle KumbierAbbott Laboratories
2018
James MullenInsulet Corporation
2017
Barbara McNeilEdwards Lifesciences Corporatio
2006
Andrea GoldsmithMedtronic plc
2019
Yoshiaki FujimoriBoston Scientific Corporation
2016
Craig ArnoldMedtronic plc
2015
William OsbornAbbott Laboratories
2013
Gregory SantoraAlign Technology
2003
Brian LarcombeSmith Nephew SNATS
2014
Phebe NovakovicAbbott Laboratories
2010

Entity Summary

Ingen Technologies, Inc., a medical device manufacturing company, manufactures medical products for the respiratory industry in United States. Ingen Technologies, Inc. was founded in 1999 and is based in Riverside, California. INGEN TECHNOLOGIES operates under Medical Devices classification in USA and is traded on BATS Exchange.INGEN TECHNOLOGIES INC [IGNT] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

INGEN TECHNOLOGIES INC Leadership Team

Christopher Wirth, Director
Stephen OHara, Director
John Finazzo, Director
Yong Khoo, Director
Thomas Neavitt, Interim CEO, CFO, Principal Accounting Officer, Controller and Director
Richard Campbell, Director
David Hanson, CEO
Charles Vorwaller, Executive VP of National Product Distribution
David Holland, Director
Gary Tilden, Chairman, Chief Operations Officer and Secretary
Curt Miedema, Director
Donn Miller, Director
Michael Cooper, Director

Stock Performance Indicators

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Market Hitters module to find equities that experience drastic asymmetry in trading patters, price, volume, or investment outlook..
Search macroaxis.com